SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MIKE DUBIS who wrote (888)8/21/1998 9:06:00 PM
From: VLAD  Read Replies (1) of 1016
 
Mike,

Please don't put words into my mouth.

I never shouted that there was gold at the end of the rainbow.

Ever since Vivus crashed in December, I have been long and have believed in the product and its niche in the ED market.
I still feel that MUSE is a viable product and if marketed effectively will be very profitable.

I would have told anybody on the long thread last year that they were crazy to buy Vivus stock for over $25.00/share but I was not a member of SI.

Right now and for the record I say that anybody who shorts or sells this stock is crazy. New Viagra scripts are off by 65% of their May highs. Total refills based on a 4 week refill time shows only a 35% refill rate. There is a real market out there for MUSE to tap but it won't happen with the current salesforce. None of us can predict the future but I don't think the future of Vivus is as bleak as the stock price would suggest.

VLAD

PS You can't acuse me of shouting "BUY BUY BUY" in any of my posts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext